The Urinary Excretion of Pyridinium Cross-links As Markers of Bone Meta Stasisin Breast Cancer

Overview

Journal Breast Cancer

Specialty Oncology

Date 1994 Dec 30

PMID 11091517

Authors

Hiraide

Okamura

Hayashi

Nishida

Tamaki

Tamakuma

Affiliations

Soon will be listed here.

Abstract

The collagen cross-links, pyridinoline (Pyr) and deoxypyridinoline (D-Pyr) excreted in urine have recently been suggested as new markers of bone metastasis. In a pilot study we measured Pyr and D-Pyr in 61 patients with breast cancer, 16 with known bone metastasis and 45 with no recognized metastasis in bone. Twenty healthy female subjects were also measured as controls. The mean values (+/-SD) of Pyr and D-Pyr in the group with bone metastasis were significantly higher (Pyr: p<0.01, D-Pyr: p <0.05) than those in the group without bone metastasis and in the control group. The mean (+/-SD) values of postmenopausal women were significantly higher than those of premenopausal in the group without bone metastasis (p<0.05) and in the control group (p<0.01). Therefore, the effect of menopause should be taken into account in the diagnosis of bone metastasis by assays of Pyr and D-Pyr. Setting the cut-off values (mean + 2SD of the values of control) for pre and postmenopausal patients, the accuracy for Pyr was 71.4% in premenopausal and 75.8% in postmenopausal patients; and for D-Pyr it was 71.4% and 78.8% respectively. We consider that measurement of urinary collagen cross-links assays can contribute to the early detection of metastatic spread to bone in breast cancer.

References

Eyre D, Koob T, Van Ness K . Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Anal Biochem. 1984; 137(2):380-8. DOI: 10.1016/0003-2697(84)90101-5. View

Robins S . Cross-linking of collagen. Isolation, structural characterization and glycosylation of pyridinoline. Biochem J. 1983; 215(1):167-73. PMC: 1152377. DOI: 10.1042/bj2150167. View

Christiansen C, Riis B, RODBRO P . Prediction of rapid bone loss in postmenopausal women. Lancet. 1987; 1(8542):1105-8. DOI: 10.1016/s0140-6736(87)91671-0. View

Blomqvist C, Elomaa I, Virkkunen P, Porkka L, Karonen S, Risteli L . The response evaluation of bone metastases in mammary carcinoma. The value of radiology, scintigraphy, and biochemical markers of bone metabolism. Cancer. 1987; 60(12):2907-12. DOI: 10.1002/1097-0142(19871215)60:12<2907::aid-cncr2820601211>3.0.co;2-b. View

Seibel M, Duncan A, Robins S . Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases. J Rheumatol. 1989; 16(7):964-70. View

Kamby C, Vejborg I, Daugaard S, Guldhammer B, Dirksen H, Rossing N . Clinical and radiologic characteristics of bone metastases in breast cancer. Cancer. 1987; 60(10):2524-31. DOI: 10.1002/1097-0142(19871115)60:10<2524::aid-cncr2820601030>3.0.co;2-3. View

Eyre D . New biomarkers of bone resorption. J Clin Endocrinol Metab. 1992; 74(3):470A-470C. DOI: 10.1210/jcem.74.3.1740477. View

Ogawa T, Ono T, Tsuda M, Kawanishi Y . A novel fluor in insoluble collagen: a crosslinking moiety in collagen molecule. Biochem Biophys Res Commun. 1982; 107(4):1252-7. DOI: 10.1016/s0006-291x(82)80132-0. View

Yoshimura Y, Ohnishi K, Hamamura M, Oda T, Sohda T . Automated high-performance liquid chromatographic determination of hydroxylysylpyridinoline and lysylpyridinoline in urine using a column-switching method. J Chromatogr. 1993; 613(1):43-9. DOI: 10.1016/0378-4347(93)80195-a. View

10.

Fujimoto D . Isolation and characterization of a fluorescent material in bovine achilles tendon collagen. Biochem Biophys Res Commun. 1977; 76(4):1124-9. DOI: 10.1016/0006-291x(77)90972-x. View

11.

Hassager C, Colwell A, Assiri A, Eastell R, Russell R, Christiansen C . Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross-links: a longitudinal and cross-sectional study. Clin Endocrinol (Oxf). 1992; 37(1):45-50. DOI: 10.1111/j.1365-2265.1992.tb02282.x. View

12.

Wada T, Hohjoh T, Matunami N, Yamato M, Kadota K, Morikawa E . [Clinical significance of bone scintigraphy for early detection of bone metastasis from breast cancer]. Nihon Gan Chiryo Gakkai Shi. 1989; 24(4):781-5. View

13.

Adachi I, Suzuki M, Tsuchihashi T, Yamaguchi K, Abe K . [Bone metastasis in advanced breast cancer]. Gan To Kagaku Ryoho. 1987; 14(5 Pt 2):1688-95. View

14.

Paterson C, Robins S, Horobin J, Preece P, Cuschieri A . Pyridinium crosslinks as markers of bone resorption in patients with breast cancer. Br J Cancer. 1991; 64(5):884-6. PMC: 1977489. DOI: 10.1038/bjc.1991.419. View

15.

Coleman R, Houston S, James I, Rodger A, Rubens R, Leonard R . Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone disease. Br J Cancer. 1992; 65(5):766-8. PMC: 1977378. DOI: 10.1038/bjc.1992.161. View

16.

Fujimoto D, Suzuki M, Uchiyama A, Miyamoto S, Inoue T . Analysis of pyridinoline, a cross-linking compound of collagen fibers, in human urine. J Biochem. 1983; 94(4):1133-6. DOI: 10.1093/oxfordjournals.jbchem.a134457. View

17.

Delmas P . Clinical use of biochemical markers of bone remodeling in osteoporosis. Bone. 1992; 13 Suppl 1:S17-21. DOI: 10.1016/s8756-3282(09)80005-7. View

18.

Uebelhart D, Schlemmer A, Johansen J, Gineyts E, Christiansen C, Delmas P . Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. J Clin Endocrinol Metab. 1991; 72(2):367-73. DOI: 10.1210/jcem-72-2-367. View

19.

Robins S, Stewart P, Astbury C, Bird H . Measurement of the cross linking compound, pyridinoline, in urine as an index of collagen degradation in joint disease. Ann Rheum Dis. 1986; 45(12):969-73. PMC: 1002034. DOI: 10.1136/ard.45.12.969. View

20.

Simon L, Krane S, Wortman P, Krane I, Kovitz K . Serum levels of type I and III procollagen fragments in Paget's disease of bone. J Clin Endocrinol Metab. 1984; 58(1):110-20. DOI: 10.1210/jcem-58-1-110. View